The prevalence and implications of ocular hypertension and glaucoma in thyroid-associated orbitopathy

被引:88
作者
Cockerham, KP
Pal, C
Jani, B
Wolter, A
Kennerdell, JS
机构
[1] WALTER REED ARMY MED CTR,DEPT SURG,OPHTHALMOL SERV,WASHINGTON,DC 20307
[2] ALLEGHENY GEN HOSP,DEPT OPHTHALMOL,PITTSBURGH,PA 15212
[3] CASE WESTERN RESERVE UNIV,DEPT OPHTHALMOL,CLEVELAND,OH 44106
关键词
D O I
10.1016/S0161-6420(97)30207-3
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The authors determined the prevalence of ocular hypertension and its association with progression to glaucomatous damage in patients with thyroid-associated orbitopathy (TAO). Methods: The charts of 500 consecutive patients with TAO seen at the Allegheny General Hospital (Pittsburgh, PA) between 1985 and 1995 were analyzed, The amount of proptosis, degree and duration of myopathy, exposure to corticosteroids, prior glaucoma treatment, and family history of glaucoma were evaluated. Results: One hundred twenty (24%) patients with TAO were noted to have an intraocular pressure (IOP) greater than 22 mmHg but less than 30 mmHg. This ocular hypertensive group was composed of 34 men and 86 women with a mean age of 55 years and mean follow-up of 4 years. Seven patients were defined as glaucoma suspects, based on increased but nonprogressive cup-to-disc ratios or nonprogressive, atypical visual field changes in the presence of increased IOP. Two patients demonstrated progressive visual field abnormalities and cupping, Of the factors evaluated, only the duration of active orbital involvement was statistically associated with progression to glaucomatous damage. The mean duration of TAO was 3, 8, and 12 years for ocular hypertensives, glaucoma suspects, and glaucomatous damage, respectively, Conclusions: Only a prolonged duration of active TAO in association with ocular hypertension correlated with progression to glaucomatous damage, These patients with chronic TAO deserve special attention and close follow-up to prevent optic nerve damage.
引用
收藏
页码:914 / 917
页数:4
相关论文
共 23 条
[1]   PREVALENCE AND CLINICAL ASSOCIATIONS OF INTRAOCULAR-PRESSURE CHANGES IN GRAVES-DISEASE [J].
ALLEN, C ;
STETZ, D ;
ROMAN, SH ;
PODOS, S ;
SOM, P ;
DAVIES, TF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (01) :183-187
[2]   DIPLOPIA IN AUTOIMMUNE THYROID-DISEASE [J].
APPEN, RE ;
WENDELBORN, D ;
NOLTEN, WE .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (05) :898-901
[3]   MALIGNANT EXOPHTHALMOS [J].
BRALEY, AE .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1953, 36 (09) :1286-1290
[4]  
Cant J S, 1974, Trans Ophthalmol Soc U K, V94, P416
[5]   THYROID DISEASE AND GLAUCOMA [J].
CHENG, H ;
PERKINS, ES .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1967, 51 (08) :547-+
[6]  
DOSSO A, 1994, J NEURO-OPHTHALMOL, V14, P170
[7]  
Dyer J.A., 1977, T AM OPHTHAL SOC, V74, P425
[8]  
FISHMAN DR, 1991, J CLIN NEURO-OPHTHAL, V11, P162
[9]   PREVALENCE OF INCREASED INTRAOCULAR-PRESSURE IN GRAVES-DISEASE - EVIDENCE OF FREQUENT SUBCLINICAL OPHTHALMOPATHY [J].
GAMBLIN, GT ;
HARPER, DG ;
GALENTINE, P ;
BUCK, DR ;
CHERNOW, B ;
EIL, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (08) :420-424
[10]   SIGNIFICANCE OF CYTOTOXIC EYE MUSCLE ANTIBODIES IN PATIENTS WITH THYROID-ASSOCIATED OPHTHALMOPATHY [J].
HIROMATSU, Y ;
CADARSO, L ;
SALVI, M ;
WALL, JR .
AUTOIMMUNITY, 1990, 5 (03) :205-213